1. |
张琳, 吴峰, 石理兰, 等. HBV携带者血清病毒标志物和HBV DNA与肝组织中HBVcccDNA相关性的研究[J].中华实验和临床病毒学杂志, 2011, 25(2):112-113.
|
2. |
Zheng Q, Zhu YY, Chen J, et al. Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss[J].J Viral Hepat, 2014, 21(12):909-916.
|
3. |
李韦杰, 李伯安, 赵景民, 等. 54例慢性乙型肝炎患者肝组织乙型肝炎病毒共价闭合环状DNA与血清HBsAg定量检测结果分析[J].中华肝脏病杂志, 2011, 19(11):815-817.
|
4. |
Chuaypen N, Sriprapun M, Praianantathavorn K, et al. Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B[J/OL].J Med Virol, 2016. https://dx.doi.org/10.1002/jmv.24601.
|
5. |
中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版)[J].中国肝脏病杂志:电子版, 2011, 19(1):13-24.
|
6. |
王文真, 卢丽霞, 王丽春. 慢性乙型肝炎核苷类似物抗病毒治疗应答的影响因素[J].华西医字, 2014, 29(9):776-779.
|
7. |
李莹, 韩涛, 马晓艳, 等. 原发性肝细胞癌患者乙型肝炎病毒表面抗原与肝组织HBVDNA水平的相关性[J].中国病毒病杂志, 2011, 36(1):32-34.
|
8. |
Volz T, Lutgehetmann M, Wachtler P, et al. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients[J].Gastroenterology, 2007, 133(3):843-852.
|
9. |
Wursthorn K, Lutgehetmann M, Dandri M, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B[J].Hepatology, 2006, 44(3):675-684.
|
10. |
Nguyen T, Thompson AJ, Bowden S, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B:a perspective on Asia[J].J Hepatol, 2010, 52(4):508-513.
|
11. |
Jaroszewicz J, Calle Serrano B, Wursthorn K, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection:a European perspective[J].J Hepatol, 2010, 52(4):514-522.
|
12. |
Chan HL, Wong VW, Wong GL, et al. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B[J].Hepatology, 2010, 52(4):1232-1241.
|
13. |
Su TH, Hsu CS, Chen CL, et al. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B[J].Antivir Ther, 2010, 15(8):1133-1139.
|
14. |
Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences[J].Antivir Ther, 2010, 15(Suppl 3):25-33.
|
15. |
Lin C, Zou H, Wang S. Hepatitis B e antigen seroconversion is related with the function of dendritic cells in chronic hepatitis B virus infection[J].Gastroenterol Res Pract, 2014, 2014:413952.
|
16. |
Marcellin P, Lada O, Asselah T. Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine[J].Hepatol Res, 2007, 37(s1):S55-S61.
|
17. |
Sonneveld MJ, Rijckborst V, Boucher CA, et al. Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline[J].Hepatology, 2010, 52(4):1251-1257.
|